United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and lif...
United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common shares
United Therapeutics Corporation $UTHR Shares Sold by KBC Group NV
Bowen Hanes & Co. Inc. Makes New Investment in United Therapeutics Corporation $UTHR
United Therapeutics director Victor J. Dzau files initial beneficial ownership statement
United Therapeutics CEO Martine A. Rothblatt disposes of 8,500 common shares worth $4.53 million
United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors | UTHR Stock News